RNAC

Cartesian Therapeutics, Inc. - Common Stock (RNAC)

About Cartesian Therapeutics, Inc. - Common Stock (RNAC)

Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company is headquartered in Gaithersburg, MD.

Details

Daily high

$12.05

Daily low

$11.51

Price at open

$11.87

52 Week High

$41.87

52 Week Low

$8.85

Market cap

312.2M

Dividend yield

0.00%

Volume

28,152

Avg. volume

131,302

P/E ratio

-.23

Cartesian Therapeutics, Inc. - Common Stock News